Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Patent
1996-08-07
1998-11-03
Ketter, James
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
435354, 536235, C12N 1500
Patent
active
058307290
ABSTRACT:
This invention relates to a method of constructing a villin gene hybrid by inserting an I-Sce I restriction site next to or within a gene or cDNA encoding a villin protein. The insertion site of the I-Sce I restriction site is chosen as to provide a first downstream part and a second upstream part from the site, containing at least twelve nucleotides of the gene or cDNA encoding the villin protein. Furthermore, the insertion of the restriction permits a high frequency of homologous recombination events. The villin gene hybrid may be used to transfect eukaryotic cells, and particularly, embryonic stem cells.
REFERENCES:
patent: 5474896 (1995-12-01), Dujon et al.
Rousseau-Merck, et al., Human Genetics, vol. 78, pp. 130-133, 1988.
Babinet Charles
Choulika Andre
Cohen-Tannoudji Michel
Jaisser Frederic
Louvard Daniel
Centre National de la Recherche Scientifique
Institut Curie
Institut Pasteur
Ketter James
Yucel Ivan
LandOfFree
I Sce I-induced gene replacement and gene conversion in embryoni does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with I Sce I-induced gene replacement and gene conversion in embryoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and I Sce I-induced gene replacement and gene conversion in embryoni will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-688379